Quantcast

Latest AstraZeneca Stories

2014-03-25 08:29:14

WARRINGTON, Pa., March 25, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced new appointments to the Company's management team. William C. Roberts has joined the Company as Vice President, Investor Relations and Corporate Communications. In addition, John A. Tattory has been appointed Senior Vice President and Chief Financial Officer. Both Mr. Roberts...

2014-03-25 00:21:44

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/s3kv36/investigation) has announced the addition of the "Investigation Report on China Budesonide Market" [http://www.researchandmarkets.com/research/s3kv36/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Asthma and allergic rhinitis are both very common diseases in the world today. As the global atmosphere...

2014-03-24 12:30:48

BASEL, Switzerland, March 24, 2014 /PRNewswire/ -- Syngenta announced today the successful issue of EUR 750 million in Eurobonds. This issue comprises a EUR 500 million Eurobond with maturity date in November 2021 and a EUR 250 million Eurobond with maturity date in October 2017. John Ramsay, CFO, said: "We have taken advantage of current favorable market conditions in order to further enhance our debt maturity profile. These bond issues are part of our...

2014-03-20 16:27:03

DUBLIN, March 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/dkkfvn/global_and ) has announced the addition of the "Global and Chinese Propofol Industry Report 2014" [http://www.researchandmarkets.com/research/dkkfvn/global_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Global and Chinese Propofol Industry Report 2014 is a professional and in-depth study on the current...

2014-03-19 04:20:42

BASEL, Switzerland, March 19, 2014 /PRNewswire/ -- Syngenta today announced that its 2013 Annual Report is now available at www.syngenta.com/ar2013. The 2013 Annual Report consists of the following documents: -- Annual Review, incorporating the Corporate Responsibility Report -- Financial Report -- Corporate Governance and Compensation Report All documents are in English and German except for the Financial Report, which is published in English only. Printed copies of these...

2014-03-16 16:20:46

CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust Sanger Institute, announced today the publication in Nature Biotechnology of a paper describing its breakthrough therapeutic antibody discovery technology, Kymouse(TM) (http://dx.doi.org). Scientists at Kymab have engineered a mouse with the full set of genes encoding the human antibody repertoire, calling this...

2014-03-12 08:29:43

BEIJING, March 12, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and whole year ended December 31, 2013, after market closes on Wednesday, March 19, 2014 EDT. The Company will host a conference call prior to the market opening on Thursday, March 20, 2014, at 8:00 a.m. EDT (Thursday, March 20, 2014 at 8:00 p.m. China Standard...

2014-03-06 08:31:20

CAMBRIDGE, Mass., March 6, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), a revolutionary treatment modality to enable the in vivo production of therapeutic proteins, announced today that Lorence Kim, M.D. will join Moderna's executive leadership team as chief financial officer effective April 21. Prior to joining Moderna, Dr. Kim was managing director and co-head of the U.S. biotechnology investment banking effort at...

2014-03-05 23:30:09

Dr. Dominick Angiolillo begins clinical study of rapid CYP2C19 genotyping in Jacksonville. Ottawa, Ontario (PRWEB) March 05, 2014 Spartan Bioscience today announced the start of a study of personalized medicine at the University of Florida. The Spartan RX CYP2C19 System is being used to test heart attack patients receiving cardiac stents. The study is entitled “A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function...

2014-03-03 00:20:29

BASEL, Switzerland, March 3, 2014 /PRNewswire/ -- -- ELATUS((TM)) fungicide receives regulatory approval in Brazil -- Delivers outstanding control of soybean rust disease -- Higher and more predictable yields for Latin American growers Syngenta today announced that ELATUS, a breakthrough foliar fungicide, has been approved by the Brazilian authorities. ELATUS is a combination of Syngenta's new SDHI chemistry SOLATENOL((TM) )and AMISTAR(®). It offers unrivaled performance...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related